PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 43 filers reported holding PROQR THRAPEUTICS N V in Q3 2020. The put-call ratio across all filers is 6.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,024,000 | -12.3% | 1,196,218 | 0.0% | 0.11% | -22.3% |
| Q3 2020 | $5,730,000 | -25.2% | 1,196,218 | -5.0% | 0.14% | -35.0% |
| Q2 2020 | $7,656,000 | +7.3% | 1,259,177 | -3.1% | 0.21% | -29.1% |
| Q1 2020 | $7,137,000 | -44.6% | 1,300,000 | 0.0% | 0.30% | -39.4% |
| Q4 2019 | $12,883,000 | +72.0% | 1,300,000 | 0.0% | 0.50% | +66.0% |
| Q3 2019 | $7,488,000 | -36.7% | 1,300,000 | 0.0% | 0.30% | -37.2% |
| Q2 2019 | $11,830,000 | -39.1% | 1,300,000 | -7.1% | 0.48% | -39.7% |
| Q1 2019 | $19,418,000 | -12.1% | 1,400,000 | 0.0% | 0.79% | -3.1% |
| Q4 2018 | $22,092,000 | -12.2% | 1,400,000 | +7.7% | 0.82% | +25.1% |
| Q3 2018 | $25,155,000 | +129.7% | 1,300,000 | -13.3% | 0.65% | +180.7% |
| Q2 2018 | $10,950,000 | +87.4% | 1,500,000 | -21.1% | 0.23% | +219.2% |
| Q1 2018 | $5,843,000 | -4.7% | 1,900,000 | 0.0% | 0.07% | -20.7% |
| Q4 2017 | $6,128,000 | -15.8% | 1,900,000 | +26.7% | 0.09% | -26.4% |
| Q3 2017 | $7,275,000 | +179.8% | 1,500,000 | +200.0% | 0.12% | +177.8% |
| Q2 2017 | $2,600,000 | +30.0% | 500,000 | +25.0% | 0.04% | +2.3% |
| Q1 2017 | $2,000,000 | – | 400,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |